Results 91 to 100 of about 33,952 (165)

Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma. [PDF]

Pharmaceuticals (Basel)
Oakley O, Mahmood U, Ahmad Y, Smyth E.
europepmc   +1 more source

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer. [PDF]

Front Immunol
Kong X, Su Y, Zheng H, Feng Z, Huang J, Zhang L, Li L.   +6 more
europepmc   +1 more source

A systematic review and network meta-analysis of first-line EGFR-TKI-based combination strategies for EGFR-mutant non-small cell lung cancer with brain metastases. [PDF]

Sci Rep
Ma J, Zhao W, Guo W, Li Z, Lu X, Yang X, Jia C, Zhou Q, Jiang J.   +8 more
europepmc   +1 more source

CLEC5A/TLR2 bispecific antibody suppresses dengue virus-induced pro-inflammatory cytokines production from macrophages. [PDF]

J Biomed Sci
Wang SH, Kuo WT, Cheng D, Sung PS, Shih SR, Hsieh SL, Wang JR.   +6 more
europepmc   +1 more source

The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune tolerance. [PDF]

Front Immunol
Sha Z, Ji Z, Zhao L, Wang S, Guo Z.
europepmc   +1 more source

Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance, 2016-2026. [PDF]

Cancer Med
Mandal S, Maji M, Dhali A.
europepmc   +1 more source

A Phase I Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients with Advanced Gastrointestinal Cancers. [PDF]

Cancer Res Commun
Fakih M, Doi T, Tolcher A, Hong D, Tie J, Messersmith W, Koyama T, Rosen L, Borlido J, Damore MA, Delioukina M, Cheronis I, Clark LN, Golmakani M, Jackson-Fisher A, Tang SY, Guo CC, Keliher EJ, Maresca K, Segal NH.   +19 more
europepmc   +1 more source

A protein-small molecule conjugate as a bispecific inhibitor of proteases implicated in cancer metastasis. [PDF]

Sci Rep
Bahat I, Pinkert Y, Baumann A, Arbely E, Miller AK, Papo N.   +5 more
europepmc   +1 more source

The Evolving Role of Bispecific Antibodies in Oncogene-Driven NSCLC. [PDF]

Cancers (Basel)
Wang JC, Rosas D, Raez LE.
europepmc   +1 more source